Enabling Breakthrough Discoveries
in small Extracellular Vesicle (sEV)/exosome Research with the first commercial service based on world leading acoustofluidics platform.
Partner with us today and experience
The Future of sEV Isolation
Real-time Isolation Demo video (@40x magnification) of 100 and 500nm fluorescent PS particles in the Acoustofluidic chip
What do we do
Acoustofluidics: fusion of Acoustics and Microfluidics for Cell
and Particle Isolation
EzerSonic® is a registered trademark owned by Ascent Bio-Nano Technologies, Inc. Ezer is pronounced “ay-zer”, Hebrew, which means divine helper. Sonic: refer to our acoustofluidics technology platform. We specialize in acoustofluidic isolation for high-yield, high-purity isolation of sEV, revolutionizing liquid biopsy for research, early-stage diagnostics, and therapeutics.
EzerSonic® SoniEV™ sEV ISOLATION SERVICE DELIVERS UNPARALLELED RESULTS:
Source: Doyle LM, Wang MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 2019 Jul 15;8(7):727. doi: 10.3390/cells8070727. PMID: 31311206; PMCID: PMC6678302.
Significance
Extracellular vesicles (EVs) are a heterogeneous population of membrane-bound particles released by cells. The isolation and purification of EVs from biological fluids are crucial steps in studying their potential for diagnostic and therapeutic applications.
The three main subtypes of EVs are microvesicles (MVs), Small Evs /exosomes, and apoptotic bodies.
Small Evs/exosomes play a major role in intercellular signaling and communication and in different physiological processes, including cellular homoeostasis, infection propagation, cancer development and cardiovascular diseases.
Researchers in the field of extracellular vesicles (EVs) have long awaited an isolation solution that combines the advantages of gentle handling, high yield, scalability and repeatability.
The wait is finally over,
Launching sEV Isolation Service
with the EzerSonic® SoniEV™ Gen1 Isolator
Powered by our proprietary and patented Acoustofluidics (fusion of Acoustics and Microfluidics) technology platform developed in Penn State University and Duke University, our cutting-edge EzerSonic® SoniEV™ sEV Isolation Service based on EzerSonic® SoniEV™ Gen1 Isolator is developed to overcome the limitations of traditional methods, enabling breakthroughs for your research and discoveries.
Our World-Leading sEV isolation Service
We offer specialized sample preparation services tailored for applications in research, personalized medicine, diagnostics, and therapeutics. Our expertise in handling extracellular vesicles (EVs) enables us to provide clients with isolated sEV samples that are pivotal for advancing scientific discoveries and enhancing patient care.
Our team of dedicated scientists and engineers work tirelessly to continuously improve our sEV isolation technology, ensuring you have access to the latest advancements and cutting-edge capabilities.
Partnering for Success
We understand that successful research is built on strong partnerships and collaboration. That’s why we strive to be more than just a service provider – we aim to be your trusted partner, working closely with you to understand your unique research goals and providing tailored solutions to meet your specific needs.
Unlock the full potential of your EV research and experience the convenience and reliability of our tailored sEV isolation service. Learn how our service can empower your next breakthrough. Contact us today to request your free trial.
We are committed to enabling breakthroughs in research and industry, enhancing health, and improving quality of life.
EzerSonic® is a registered trademark owned by Ascent Bio-Nano Technologies.
About Us
EzerSonic® is a registered trademark owned by Ascent Bio-Nano Technologies, Inc. Ezer is pronounced “ay-zer”, in Hebrew means divine helper. Sonic refers to our acoustofluidics technology platform.
Ascent focuses on development and commercialization of acoustofluidic (i.e., the fusion of acoustics and microfluidics) chips and instruments for research, diagnostic, and therapeutic applications. It has a strong IP portfolio on acoustofluidic technologies (exclusive license for 4 issued US patents and >10 issued/pending patents in China, Japan, Europe, and North America).
Supported by various award leading mentoring and business service programs
Our Capabilities
Commercialize the world-leading Acoustofluidics Platform to enable breakthroughs
Our comprehensive services span the entire product development lifecycle, from early-stage proof-of-concept testing, full-scale prototype development and validation, to fabrication and assembly.
We take great pride in developing and fabricating acoustofluidic and instrument chips in North Carolina, USA, adhering to the highest quality standards.
Delivering Unparalleled Results
Exosome Isolation Using Sound Waves
Enabling Breakthroughs
Our numerous collaborations and case studies highlight the efficiency of our sEV isolation technology, consistently outperforming traditional methods and redefining industry standards.
Supported by many organizations
Collaboration partners
Academic collaborators
